Stay updated on Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this appears to be a version label rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-03-12T02:25:16.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page adds a revision tag 'Revision: v3.4.2' and removes a government funding notice that was previously shown. These changes affect only site-wide information and do not alter the study details, eligibility criteria, outcomes, or contacts.
    Difference
    0.5%
    Check dated 2026-02-11T14:34:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A funding-lapse notice was added at the top of the page and the revision tag updated to v3.4.1, replacing the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:39:08.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A 'Show glossary' option has been added to the page. QC-related labels were updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and the revision stamp now shows v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:38:23.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The only observed change is the revision label updated from v3.3.3 to v3.3.4, with no visible updates to study details, eligibility criteria, or other page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:22:07.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-12-23T20:25:48.000Z thumbnail image

Stay in the know with updates to Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page.